| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥67.3B | ¥74.1B | -9.2% |
| Operating Income | ¥2.8B | ¥3.2B | -12.2% |
| Ordinary Income | ¥1.2B | ¥1.4B | -16.7% |
| Net Income | ¥1.0B | ¥1.0B | +0.0% |
| ROE | 1.9% | 2.0% | - |
FY2026 Q3 results show revenue of 6.73 billion yen (YoY -9.2%), operating income of 284 million yen (YoY -12.2%), ordinary income of 123 million yen (YoY -16.7%), and net income of 96 million yen (YoY flat at 0.0%). The company experienced a decline in top-line performance with proportional pressure on operating profitability, while net income was maintained at prior year levels through tax and non-operating adjustments. Operating margin compressed to 4.2% from 4.3% in the prior year, reflecting challenges in cost absorption amid lower sales volumes. The gap between operating income and ordinary income widened by 161 million yen, primarily driven by interest expense of 61 million yen against modest non-operating income, indicating elevated financial costs relative to operational earnings. Net income stability despite ordinary income decline of 16.7% was supported by effective tax rate management and absence of extraordinary losses.
Revenue declined 9.2% YoY to 6.73 billion yen, driven by softness across both reporting segments. The Chemicals segment recorded sales of 5.996 billion yen with operating income of 594 million yen, representing the core business with approximately 89% of total segment sales. The Household Products segment contributed sales of 732 million yen with operating income of 59 million yen, accounting for the remaining 11% of segment sales. Gross profit of 1.099 billion yen yielded a gross margin of 16.3%, indicating pressure from product mix deterioration or competitive pricing dynamics. Selling, general and administrative expenses totaled 814 million yen, representing 12.1% of revenue, which combined with the compressed gross margin resulted in operating income of 284 million yen and an operating margin of 4.2%. The decline in operating income of 12.2% YoY outpaced the revenue decline, suggesting fixed cost deleverage and insufficient expense scaling. Non-operating expenses created a net burden of 165 million yen, primarily from interest expense of 61 million yen, which consumed approximately 21% of operating income. This resulted in ordinary income of 123 million yen, down 16.7% YoY. Income before taxes reached 162 million yen after minimal extraordinary items, and after deducting income taxes of 65 million yen (effective tax rate of 40.2%), net income settled at 96 million yen, flat YoY. The maintenance of net income despite declining operating and ordinary income reflects a favorable tax comparison and absence of impairment charges or restructuring costs. This represents a revenue down, profit down pattern with partial profit preservation at the net income level through non-operating and tax factors.
The Chemicals segment generated sales of 5.996 billion yen and operating income of 594 million yen, yielding a segment operating margin of 9.9%. As the core business representing 89% of total segment sales, Chemicals demonstrates superior profitability relative to the company average. The Household Products segment recorded sales of 732 million yen with operating income of 59 million yen, producing a segment margin of 8.0%. While both segments contribute positively to operating profit, the Chemicals segment exhibits a 1.9 percentage point margin advantage, suggesting better pricing power or cost efficiency. The significant margin differential between segment operating margins (8-10% range) and consolidated operating margin (4.2%) indicates substantial corporate overhead or unallocated costs that compress overall profitability. Segment disclosure confirms that revenue weakness is broad-based rather than isolated to a single business line.
[Profitability] ROE stands at 1.9%, significantly below historical performance and indicating weak capital efficiency. Net profit margin of 1.4% reflects the compression from non-operating costs and tax burden. Operating margin of 4.2% declined from 4.3% YoY, constrained by gross margin pressure at 16.3% and SG&A expenses at 12.1% of revenue. DuPont decomposition shows ROE driven by net profit margin of 1.4%, total asset turnover of 0.507 times, and financial leverage of 2.69 times, with the low profit margin being the primary constraint on return on equity. [Cash Quality] Cash and deposits decreased 25.0% YoY to 1.611 billion yen, reducing liquidity cushion. Short-term debt coverage measured as cash to short-term borrowings stands at 0.70 times, below the threshold for comfortable coverage. Interest bearing debt totals 4.187 billion yen, comprised of 2.289 billion yen in short-term borrowings and 1.898 billion yen in long-term debt. [Investment Efficiency] Total asset turnover of 0.507 times reflects slow capital velocity, with inventory of 3.137 billion yen representing 23.6% of total assets and suggesting extended holding periods. Receivables of 2.252 billion yen contribute to working capital requirements. [Financial Health] Equity ratio improved to 37.1% from 35.9% YoY, though remains below comfortable levels given the high proportion of interest-bearing liabilities. Current ratio of 142.2% provides adequate short-term liquidity coverage, while quick ratio of 85.8% indicates reduced liquidity when excluding inventory. Debt-to-equity ratio of 1.69 times reflects elevated leverage. The composition of liabilities shows short-term liabilities at 5.565 billion yen (54.7% of total liabilities), creating refinancing and maturity mismatch considerations.
Cash and deposits decreased 5.38 billion yen YoY to 1.611 billion yen, representing a 25.0% contraction in liquidity position that warrants attention. While net income of 96 million yen was maintained flat YoY, the significant cash decline suggests substantial working capital outflows or investing activities during the period. Inventory increased 5.93 billion yen YoY to 3.137 billion yen, a 23.3% expansion that ties up operating capital and indicates either demand softness leading to stock accumulation or strategic inventory building. Accounts receivable of 2.252 billion yen and electronically recorded monetary claims of 57 million yen represent customer credit extensions that delay cash realization. On the liability side, accounts payable increased to 1.147 billion yen while electronically recorded obligations reached 453 million yen, providing some supplier credit benefit. Short-term borrowings of 2.289 billion yen represent 142% of available cash, creating a structural liquidity gap that requires either operating cash generation or refinancing to address maturing obligations. The divergence between stable net income and declining cash position points to cash quality concerns, with working capital expansion and inventory buildup absorbing generated earnings. Total assets remained relatively stable at 13.272 billion yen versus 13.295 billion yen prior year, but the internal composition shifted toward lower liquidity assets. The ratio of cash to short-term liabilities stands at 0.29 times, well below the 1.0 times threshold for comfortable short-term coverage, elevating refinancing risk for the 5.565 billion yen in current liabilities.
Ordinary income of 123 million yen versus operating income of 284 million yen indicates a non-operating net burden of approximately 161 million yen, representing 2.4% of revenue. The primary component is interest expense of 61 million yen, which consumes 21.5% of operating income and highlights the material impact of financial costs on profitability. Non-operating income includes dividend income of 9 million yen and interest income of 1 million yen, totaling 10 million yen, which is insufficient to offset the interest burden. The EBIT to interest coverage ratio stands at approximately 4.7 times when treating operating income as proxy for EBIT, indicating adequate but not strong coverage. The gap between ordinary income and net income narrowed to 39 million yen after taxes of 65 million yen (effective tax rate 40.2%), with no material extraordinary items recorded. Operating cash flow data is not disclosed in this quarterly period, preventing direct assessment of cash earnings quality through OCF to net income comparison. However, the 25% decline in cash balances concurrent with stable net income suggests that accruals or working capital absorption are limiting cash generation. The company reported no impairment losses or significant non-recurring charges in the period, supporting the recurring nature of reported earnings. The elevated effective tax rate of 40.2% creates a drag on after-tax returns but represents a recurring cost structure. Overall earnings quality shows vulnerability from high interest burden relative to operating profit and working capital expansion that does not convert profits to cash, though the absence of non-recurring charges supports baseline earnings sustainability.
Full-year guidance targets revenue of 9.0 billion yen, operating income of 350 million yen, ordinary income of 130 million yen, and net income of 230 million yen, with projected YoY changes of -7.3%, -13.0%, -25.1%, and +79.6% respectively. Q3 cumulative results show revenue of 6.73 billion yen representing 74.8% progress against full-year guidance, operating income of 284 million yen representing 81.1% progress, and ordinary income of 123 million yen representing 94.6% progress. Standard Q3 progress expectation stands at 75%, meaning revenue and operating income are tracking in line with seasonal patterns. However, ordinary income progress of 94.6% indicates that Q3 has already captured nearly the full-year target, leaving only 7 million yen (5.4%) to be generated in Q4. This suggests either non-operating expenses are expected to accelerate in Q4, or the original guidance embedded conservative assumptions. Net income of 96 million yen represents 41.7% progress versus the 230 million yen full-year target, implying that 134 million yen or 58.3% of annual net income is projected for Q4 alone. This back-loaded profit profile requires strong Q4 operational performance and favorable tax timing. The guidance implies Q4 revenue of 2.27 billion yen, a 25.2% quarterly contribution, which is achievable under normal seasonality. However, the required Q4 net income of 134 million yen exceeds the Q3 cumulative total, demanding scrutiny of the profit drivers and sustainability. Planned annual dividend of 5.0 yen per share corresponds to a payout ratio that aligns with the net income guidance, assuming share count stability.
Annual dividend is planned at 5.0 yen per share for the full year per company guidance. Based on Q3 interim results showing net income of 96 million yen and applying the disclosed interim dividend of 3.50 yen per share for the period-end, the calculated payout ratio stands at approximately 60.6% when annualizing the interim result. However, with full-year net income guidance of 230 million yen, the planned 5.0 yen dividend represents a more sustainable payout ratio of approximately 37.6% on a full-year basis, assuming the profit target is achieved. No share buyback programs or total return targets are disclosed in the available data. The dividend policy appears moderately aggressive given the current cash position of 1.611 billion yen and cash decline of 25% YoY, combined with short-term borrowings of 2.289 billion yen that exceed available cash. Dividend sustainability depends on Q4 profit realization and working capital management to generate sufficient operating cash flow. The combination of high inventory levels, receivables balances, and limited cash cushion relative to near-term debt obligations suggests that dividend coverage warrants monitoring, particularly if Q4 profit targets are not achieved or if working capital continues to absorb cash.
Revenue volume risk from demand softness or market share loss, evidenced by YoY sales decline of 9.2% that outpaced industry median contraction. Failure to stabilize top-line would further pressure fixed cost absorption and operating margins, potentially causing full-year guidance shortfall. Working capital liquidity risk from inventory accumulation of 3.137 billion yen (up 23.3% YoY) and extended receivables collection, combined with cash decline of 25% to 1.611 billion yen. This creates a structural mismatch where cash holdings at 70% of short-term borrowings (2.289 billion yen) elevate refinancing pressure and limit operational flexibility. Interest rate and refinancing risk from total interest-bearing debt of 4.187 billion yen with 54.7% classified as short-term liabilities, consuming 21.5% of operating income in interest expense. Rising rates or tightening credit conditions could materially impact net profitability and debt service capacity given the current interest coverage ratio of 4.7 times.
[Industry Position] (Reference - Proprietary Analysis) The company operates in the manufacturing sector and shows profitability metrics below industry standards. ROE of 1.9% significantly underperforms the industry median of 5.2% (2025-Q3, n=100), ranking in the bottom quartile and indicating substantial room for capital efficiency improvement. Operating margin of 4.2% falls well below the industry median of 8.7% (IQR: 5.1%-12.6%, n=100), placing the company in the lower performance tier and suggesting either cost structure disadvantages or pricing pressure relative to peers. Net profit margin of 1.4% trails the industry median of 6.4% (IQR: 3.3%-9.3%, n=100) by 5.0 percentage points, reflecting the compounding effect of below-median operating margins and above-average interest burden. Revenue growth of -9.2% YoY compares unfavorably to the industry median of +2.8% (IQR: -1.7% to +8.1%, n=100), indicating market share loss or end-market exposure to declining segments. Asset turnover of 0.507 times is below the industry median of 0.58 times (IQR: 0.41-0.66, n=100), consistent with elevated inventory levels at 23.6% of total assets. Financial health metrics show mixed positioning. Equity ratio of 37.1% substantially trails the industry median of 63.8% (IQR: 49.4%-74.5%, n=100), reflecting higher financial leverage and lower financial flexibility. Current ratio of 142.2% (or 1.42 times) underperforms the industry median of 2.83 times (IQR: 2.11x-3.80x, n=82), indicating tighter short-term liquidity relative to sector norms. Working capital efficiency measured by operating working capital turnover days and inventory turnover days of approximately 169 days significantly exceeds the industry median inventory turnover of 109 days (IQR: 50-155 days, n=92), confirming inventory management as an area requiring improvement. The company's financial leverage of 2.69 times exceeds the industry median of 1.53 times (IQR: 1.31-1.86, n=100), explaining the elevated interest burden. Overall, the company ranks below median across key profitability, efficiency, and financial health metrics within the manufacturing sector, with particular underperformance in return on equity, operating margin, and revenue growth. (Industry: Manufacturing, N=100 companies, Comparison period: 2025-Q3, Source: Proprietary analysis)
Capital efficiency restoration required, as ROE of 1.9% significantly trails the 5-year sector average and cost of capital, driven by operating margin compression to 4.2% and elevated financial leverage of 2.69 times. Improvement pathway requires simultaneous gross margin expansion through product mix optimization or pricing discipline, and operating expense ratio reduction through fixed cost rationalization. Working capital optimization represents the most immediate value creation opportunity, with inventory buildup of 23.3% YoY and cash conversion challenges absorbing earnings and creating 1.611 billion yen cash position that covers only 70% of short-term borrowings. Accelerated inventory turnover and receivables collection could release substantial trapped capital, reduce reliance on short-term financing, and improve free cash flow generation. The progression from operating income of 284 million yen to ordinary income of 123 million yen demonstrates the material profit leakage from interest expense of 61 million yen, suggesting that debt reduction or refinancing into lower-cost instruments would yield measurable bottom-line benefits and support dividend sustainability beyond the current 60.6% interim payout ratio.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.